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Effects of halothane and isoflurane anaesthesia on microcirculatory
blood flow in musculocutaneous flaps
G. H. SIGURDSSON, A. BANIC, A. M. WHEATLEY AND D. METTLER
Summary
Hypoperfusion and necrosis in musculocutaneous
flaps used for reconstruction of tissue defects is still
a significant clinical problem. Although the causes
of hypoperfusion are frequently surgical in nature,
little is known about the effects of anaesthetic
management on blood flow in flaps or the outcome
of flap surgery. We compared in minipigs the effects
of halothane and isoflurane anaesthesia in equi-
potent doses on microcirculatory blood flow (MBF)
in the skin and muscle part of musculocutaneous
flaps and also in intact (control) skin and muscle.
Measurements were made during stable normo-
volaemic conditions and during mild to moderate
hypovolaemia (withdrawal of 5%, 10% and 15% of
total blood volume). Multi-channel laser Doppler
flowmetry (LDF) was used to measure MBF and
electromagnetic flowmetry (EMF) for total flap
blood flow. During normovolaemic conditions there
was no significant difference between the two
groups in central haemodynamic or respiratory data.
After 15% blood loss, however, there was a
significant decrease in mean arterial pressure and
cardiac output in the halothane group while there
was no significant change in the isoflurane group
(P < 0.05). MBF in control skin, control muscle
and flap muscle remained approximately 10-15%
higher in the isoflurane than in the halothane group
throughout the study. In the isoflurane group, MBF
in flap skin was unchanged during normovolaemia
and there was less than 10% decrease during
hypovolaemia. In the halothane group hypo-
volaemia caused a significant decrease in MBF in
flap skin: 27% decrease after 5% blood loss, 45%
decrease after 10% blood loss and 49% decrease
after 15% blood loss compared with 5%, 20% and
21 %, respectively, in intact skin. We conclude that
during normovolaemic conditions MBF was well
maintained in musculocutaneous flaps in minipigs
both with halothane and isoflurane anaesthesia;
however, during mild to moderate hypovolemia
MBF decreased markedly in flap skin with
halothane anaesthesia while it remained unchanged
with isoflurane. (Br. J. Anaesth. 1994; 73:
826-832)
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Musculocutaneous flaps are used frequently in
plastic surgery to reconstruct muscle and skin defects
after trauma or radical surgery of malignant tumours
[1,2]. With improved understanding of the anatomy
and physiology of flaps and improved microsurgical
techniques, the outcome of arterial (only attached by
the intact feeding artery and vein) and free musculo-
cutaneous flap transfers have become more pre-
dictable. However, there is still a failure rate (flap
necrosis) which can cause severe morbidity [3—6]. It
has been shown that flap ischaemia is frequently
caused by obstruction of the feeding artery or other
surgical problems [3, 5, 7, 8].
Flap operations are frequently extensive and
prolonged procedures (8-12 h is not uncommon)
which may result in hypothermia [9, 10], progressive
fluid and blood loss leading to vasoconstriction and
decreased blood flow [11, 12] and possibly flap
ischaemia. Although the effects of general anaes-
thesia on arterial pressure, cardiac output and
regional blood flow are well documented [13-17],
little is known about the effects of anaesthetics, such
as halothane and isoflurane, on blood flow in free or
arterial flaps. Free and arterial flaps are unique
tissues in that, although they have an arterial blood
supply and venous drainage, they lack lymphatic
drainage, which frequently causes flap oedema. In
addition, while the flap is completely denervated, the
proximal part of the supplying artery is innervated
and the vessels in the flap respond to mechanical and
humoral stimuli [18]. Thus arterial and free flaps
may not respond to anaesthetics in the same way as
tissues in situ.
With the recent availability of multichannel laser
Doppler flowmeters, continuous monitoring of micro-
circulatory blood flow (MBF) simultaneously in
multiple organs has become possible [19-21]. Using
this technique we have compared the effects of
halothane and isoflurane on blood flow in both flap
skin and muscle and in contralateral muscle and skin
(in situ) in normovolaemic minipigs and during mild
to moderate hypovolaemia. To mimic conditions
during free flap surgery, the flap feeding artery was
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clamped for 90 min (approximates the ischaemia
encountered during the performance of two
microvascular anastomoses) and both the flap artery
and vein were denervated pharmacologically.
Materials and methods
This study was performed according to the NIH
guidelines for the use of experimental animals and
was approved by the Animal Ethics Committee of
Canton Berne. Fourteen fasted minipigs (23-28 kg)
were given ketamine 10 mg/kg body weight i.m.
followed 10 min later by metomidate 5 mg/kg body
weight and azaperone 2 mg/kg body weight i.v. for
tracheal intubation. Anaesthesia was maintained
with either 0.50 + 0.05% halothane (end-tidal con-
centration; group H, n = 7) or 1.00 + 0.09%
isoflurane (end-tidal concentration; group I, n = 7)
and 70% nitrous oxide in oxygen [22, 23]. Inhaled
and exhaled concentrations of nitrous oxide,
halothane and isoflurane were monitored continu-
ously with a multi-gas analyser (Hellige SMU 611,
Hellige, Freiburg, Germany). Continuous i.v.
infusions of fentanyl 4 ug/kg body weight/h and
pancuronium 0.5 mg/kg body weight/h were ad-
ministered to both groups. The lungs were ventilated
with a volume-controlled ventilator with a positive
end-expiratory pressure (PEEP 3-4 cm H2O)
(Tiberius 19, Dragerwerk, Liibeck, Germany). Tidal
volume was maintained at 10 ml/kg body weight and
ventilatory frequency adjusted (13-18 b.p.m.) to
maintain PaCo2 at 4.5-5.5 kPa. Abdominal aortic,
pulmonary artery (Arrow, Reading, PA, USA) and
central venous catheters were inserted via the femoral
artery and veins.
The pectoralis ascendens muscle with overlying
skin was chosen as a musculocutaneous flap. The
skin incision was made in the midline over the
sternum and extended slightly laterally over the
jugular vein to the neck. A skin island, measuring
15 x 10 cm with its long axis parallel to the sternum
and the distal tip at the xiphoid, was designed and
skin incision completed. The skin was dissected free
from the pectoralis transversus and the descendens
muscles and from the jugular vein. After transection
of both muscles, the pectoralis ascendens [24]
(pectoralis profundus [25]) muscle was exposed. The
pectoralis ascendens muscle was detached from its
origin on the humerus in order to expose the brachial
vessels and the brachial nerve plexus. The feeding
artery of the pectoralis ascendens muscle is the
external thoracic artery that derives typically as the
first branch of the axillary artery at the level of the
first rib. The length of the external thoracic artery
measures about 2 cm and the diameter about
1-1.5 mm. The brachial artery measures about 1 cm
in length between the appearance from the chest and
the origin of the external thoracic artery and has a
diameter of about 3 mm. The rest of the muscle with
the skin island was dissected free and all perforators
ligated.
A laser Doppler flow (LDF) probe was sutured
centrally on the muscle surface of the flap. Through
a small skin incision over the pectoralis muscle on
the contralateral side another LDF probe was
sutured on the surface of the intact muscle. Two
LDF probes were also sutured centrally on the flap
skin and on the contralateral intact skin. An
electromagnetic flow (EMF) probe of the appropriate
size was placed around the feeding artery to the flap.
The probe size was determined during surgery such
that the diameter of the artery was approximately
30 % larger than the measurement window.
After completion of surgery, the flap feeding
artery was clamped for 90 min to simulate the
ischaemia time during the performance of two
microvascular anastomoses in free flap surgery.
Thereafter, the flap was transposed from the body
and placed on a thermostatically controlled warming
device to keep the flap temperature constant at
36.5-37.5 °C (Micro-Temp-Pump SMS-2000,
Seabrook Medical Systems, Medizintechnik,
Giimligen, Switzerland) which was monitored con-
tinuously with a needle probe thermometer (Ther-
mometer TTX-181, Pro vet, Naumburg, Germany)
placed centrally in the flap muscle. Before
declamping and until the end of the experiment, the
feeding artery and the draining vein were irrigated
externally every 20 min with 1 % lignocaine to ensure
complete denervation.
After a 20-min stabilization period measurements
of LDF, EMF, respiratory and central haemo-
dynamic variables were performed for 60 min during
stable anaesthetic and haemodynamic conditions.
The animals were then exposed to graded hypo-
volaemia. Five percent of the total blood volume
(TBV was estimated to be 7 % of body weight) was
taken every 15 min until 15 % of the TBV had been
removed. Blood was collected in sterile blood bags
containing anticoagulant solution. Thirty minutes
after the last bleed the shed blood was reinfused over
30 min and continuous monitoring of cardiovascular
and haemodynamic variables continued for an ad-
ditional 60 min. At the end of the experiment, the
animals were killed with an overdose of anaesthetic.
During surgery the animals received Ringer's
lactate 6 ml kg"1 h"' and 5 % glucose 2 ml kg"1 h"1,
which kept central venous and pulmonary capillary
wedge pressures constant. After surgery the rate of
infusion of Ringer's lactate was reduced to
3 ml kg"1 h"1. The body temperature of the animals
was maintained at 37.5 + 0.5 °C using two heating
blankets.
HAEMODYNAMIC MONITORING
Mean arterial pressure (MAP), central venous press-
ure (CVP), mean pulmonary artery pressure (PAP)
and pulmonary capillary wedge pressure (PCWP)
were recorded with quartz pressure transducers
(129A, Hewlett-Packard, Andover, MA, USA) and
displayed continuously on a multi-modular monitor
(Hellige SMU 611, Hellige AG, Freiburg, Germany)
and recorder (Hellige SMR 821, Hellige AG,
Freiburg, Germany). Heart rate (HR) was measured
from the ECG which was also monitored con-
tinuously. Cardiac output (CO) was measured by a
thermodilution technique (mean value of three
measurements, cardiac output module, Hellige SMU
611, Hellige AG, Freiburg, Germany). Central
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Table I Mean (SD) haemodynamic, respiratory and laboratory data in the two groups (H = halothane, I =
isoflurane) during normovolaemia (30 and 60 min after end of surgery), during 5%, 10% and 15% blood loss,
and 15 min after reinfusion of shed blood. Heart rate (HR), mean pulmonary artery pressure (PAP), pulmonary
capillary wedge pressure (PCWP), central venous pressure (CVP), haemoglobin concentration (Hb), arterial
oxygen tension (Pa^) and arterial carbon dioxide tension (Pacc,2) were measured. *P < 0.05, **P < 0.01 between
groups
HR (beat min"1)
H
I
PAP (mm Hg)
H
I
PCWP (mm Hg)
H
I
CVP (mm Hg)
H
I
PaOz (kPa)
H
I
PaCO2 (kPa)
H
I
Hb (g dl"1)
H
I
Normovolaemia
30 min
95 (7)
92 (12)
24 (3)
24 (4)
12 (2)
14 (2)
11 (1)
12 (1)
14.1 (0.9)
13.2(0.8)
4.9 (0.4)
4.8 (0.4)
9.6(1.0)
9.4 (0.7)
60 min
104
92
25
25
12
14
11
12
(10)
(10)
(3)
(3)
(2)
(2)
(2)
(1)
13.6 (0.8)
13.
5.
4
9.
9.
.5 (0.7)
.2 (0.7)
.9 (0.5)
7(1.0)
.5(1.2)
Hypovolaemia
5 %
113
96
24
24
12
13
11
11
(7)
(9)*
(3)
(3)
(3)
(2)
(2)
(1)
14.0(0.8)
13.1
5.5
5.1
9.6
(0.7)
(0.7)
(0.4)
(0.9)
9.4 (0.6)
10%
109 (9)
99 (11)
23 (3)
23 (2)
12 (3)
12 (2)
11 (2)
11 (1)
13.3(0.7)
12.9 (0.5)
5.5 (0.8)
4.8 (0.5)
9.4(1.1)
9.3 (0.8)
15%
107 (14)
100 (12)
22 (3)
23 (3)
11 (2)
12 (2)
10 (2)
10 (1)
13.2 (0.8)
13.1 (0.5)
5.2(0.5)
4.9 (0.5)
9.4 (0.8)
9.1 (0.7)
Reinfusion
129 (15)
104 (13)**
29 (5)
26 (4)
14 (4)
13 (2)
13 (2)
12 (1)
12.9 (0.9)
12.8 (0.8)
5.6 (0.8)
5.2 (0.7)
9.5 (0.8)
9.5 (0.8)
venous blood temperature was recorded from the
thermistor in the pulmonary artery catheter. Blood
samples for haemoglobin (Hb) and packed cell
volume analysis were obtained from the aortic artery
catheter.
RESPIRATORY MONITORING
Expired minute volume ventilation, tidal volume,
ventilatory frequency, PEEP, peak and end-inspira-
tory pressures, inspired and end-tidal carbon dioxide
concentration and inspired and expired oxygen
concentrations were monitored continuously
throughout the study. Respiratory compliance (chest
wall and lung) was calculated as expiratory tidal
volume ( F T ) divided by end-inspiratory airway
pressure minus PEEP (Paw). Both values were
recorded simultaneously from the ventilator. Blood
samples for arterial blood-gas analysis were obtained
from the aortic artery catheter and analysed im-
mediately (temperature corrected) in a blood-gas
analyser (Ciba Corning 278 Blood Gas System,
Diagnostics Corp., Medfield, MA, USA).
ELECTROMAGNETIC FLOWMETRY
Blood flow in the feeding artery of the flap was
monitored continuously with a square-wave electro-
magnetic flowmeter (EMF) using a blood flow
transducer (Flo-Probe SP 7515-020 or -030,
Spectramed Inc., Oxnard, CA, USA) connected to a
blood flowmeter (Gould SP2202, Spectramed Inc.,
Oxnard, CA, USA).
LASER DOPPLER FLOWMETRY
MBF was monitored continuously with two double-
channel laser Doppler systems (Periflux 4001 Mas-
ter, Perimed AB, Jarfalla, Sweden) allowing four
simultaneous LDF measurements. Standard probes
(PF 408) were used for monitoring skin, and angled
probes (PF 404) for monitoring muscle blood flow.
The flow probes measured both flap skin and muscle,
and also contralateral muscle and skin (control). The
time constant of the flowmeter output amplifier was
set at 3 s. LDF data were acquired online via a
multichannel interface (Mac Paq MP 100, Biopac
Systems Inc., Goleta, CA, USA) with acquisition-
analysis software (Acqknowledge 881 3.0,
Biopac Systems Inc.) to a portable computer
(Macintosh Powerbook 180C, Apple Computer
Inc., Cupertino, CA, USA).
A detailed description of the theory of LDF
operation and practical details of LDF measure-
ments have been described previously [20, 26, 27].
Briefly, low energy laser light from a solid state diode
laser operating at 780 nm (Perimed PF4001) is
guided to the measurement site via an optical fibre.
Two identical adjacent fibres receive back scattered
light from the tissue which is then transmitted to
independent photodetectors. This back scattered
portion consists of light scattered from the static
tissue matrix which has not been Doppler shifted
and a spectrally broadened component resulting
from interactions with moving blood cells. Optical
mixing of these components at the photodetector
surface produces an electrical signal containing all
the Doppler frequency shift information. Further
processing within the frequency range 20 Hz-25 kHz
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produces an output voltage which varies linearly
with the product of mean blood cell speed and
concentration [28, 29]. The product of mean blood
cell speed and concentration is referred to correctly
as blood cell flux, but as flow rate may also be defined
as volume flux, then as long as the number of red
cells within a volume of blood remains constant,
blood cell flux is proportional to volume flux or flow
of blood. The sensitivity of the laser Doppler system
was checked using a calibration standard consisting
of a suspension of 2-mm latex spheres (Perimed,
Jarfalla, Sweden). This produced a standard
deflection of 2.5 V or 250 PU on the recorder.
STATISTICS
The Wilcoxon rank sum test (non-parametric) was
used to describe differences between the two an-
aesthetic groups, between flap skin and control skin
or flap muscle and control muscle. All data are
presented as mean (SEM). P < 0.05 was considered
statistically significant.
Results
Results for systemic haemodynamic, respiratory and
laboratory data are summarized in table 1 and figures
1 and 2. Total flap blood flow, measured by EMF, is
presented in figure 3. Microcirculatory blood flow,
measured by LDF in the muscle and skin of the
flaps, and also in control skin and muscle, is
presented in figures 4 and 5.
During normovolaemic conditions there was no
statistically significant difference between groups H
and I in any of the variables monitored. During
hypovolaemia (15' , , blood loss) however, there was
a significant decrease in MAP and CO in group H (P
<0.05 ; fig 1 and 2) but no significant change in
group I. MAP decreased by 7 ",, in group H and 5 ",,
in group I after 5 ",, blood loss, 17 ",, in group H and
9",, in group I after 10",, blood loss and 30",, in
group H and 15",, in group I after 15",, blood loss
(fig.lj. CO decreased in a similar fashion to MAP in
both groups during blood loss frig. 2;. Total blood
flow (EMF) to the musculocutaneous flap decreased
by 35",, in group H and 8",, in group I after 5",,
blood loss, 50",, in group H and 26",, in group I
after 10",, blood loss, and 60",, in group H and 40%
in group I after 15",, blood loss (fig. 3).
MBF (LDF) in control skin and muscle, and in
flap muscle was approximately 10-15 ",, higher in the
isoflurane than in the halothane group throughout
the study ffigs 4, 5). In flap skin, MBF was
unchanged during hypovolaemia in group I 'no
change after 5",, blood loss, 7",, decrease after 10",,
blood loss and 9",, decrease after 15",, blood loss
compared with 4",,, 14",, and 15",,, respectively, in
intact skin;. In group H, however, there was a
significant decrease in blood flow in flap skin '21",,
decrease after 5",, blood loss, 45",, decrease after
10",, blood loss and 49",, decrease after 15",, blood
loss compared with 5",,, 20",, and 21", , , respect-
ively, in intact skin;.
ively, in intact skin).
40
Normo Normo.
Figure 1 Mean arterial pressure MAP in the halothane • >
and isoflurane Q groups during normovolaemia 'Normo.) (30
and 60 min after end of surgery during 5".,, 10",,and 15",,
blood loss, and 15 min after reinfusion of shed blood (mean,
SEMi. *P < 0.05 between groups.
1.0
Normo. Normo.
Figure 2 Cardiac output (Co) in the halothane • and
isoflurane eg) groups during normovolaemia (Normo.) (30 and
60 min after end of surgery;, during 5 ",,, 10",, and 15 ",, blood
loss, and 15 min after reinfusion of shed blood mean, SEM,-. *P
< 0.05 between groups.
Normo. Hypovolaemia Normo.
Figure ? Total blood flow TBFj to the musculocutaneous
flaps, measured by electromagnetic flowmetry in the halothane
• and isoflurane ' 0 groups during normovolaemia Normo.
'30 and 60 min after end of surgery,, during 5 ',,, 10",, and
15",, blood loss, and 15 min after reinfusion of shed blood
mean, SEM;.
Discussion
The pig model was chosen for this study for two
main reasons. First, anatomically the vascularization
of pig skin is quite similar to humans [30-32] and
pathophysiologically it also appears more relevant
ui pig sum lb quite similar to numans
pathophysiologically it also appears more relevant
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Figure 4 Microcirculatory blood flow (MBF) in flap muscle ( • = halothane, §| = isoflurane) and control muscle
(M — halothane, D = isoflurane), measured by laser Doppler flowmetry (perfusion units, PU) during
normovolaemia (Normo.) (30 and 60 min after end of surgery), during 5 %, 10% and 15 % blood loss, and 15 min
after reinfusion of shed blood (mean, SEM). *P < 0.05 between flap and control muscle in the halothane group.
CO
30 min 60 min 5% loss 10% loss 15% loss Reinfusion
Normo. Hypovolaer Normo
Figure 5 Microcirculatory blood flow (MBF) in flap skin ( • = halothane, H = isoflurane) and control skin (fll
halothane, • = isoflurane), measured by laser Doppler flowmetry (perfusion units, PU) during normovolaemia
(Normo.) (30 and 60 min after end of surgery), during 5%, 10% and 15% blood floss, and 15 min after
reinfusion of shed blood (mean, SEM). *P < 0.05, **P < 0.01 between groups in flap skin blood flow; fP < 0.05
between flap and control skin in the halothane group.
for human comparison than rodents [32]. The latter
have higher concentrations of the enzyme xanthine
oxidase in skin and therefore produce higher con-
centrations of oxygen radicals during ischaemia and
reperfusion than appears to be the case in pigs and
humans [33]. Second, the central and coronary
circulations of the pig are remarkably similar to those
of humans [34]. The anaesthetics used were
administered in equipotent doses. One MAC for
halothane in pigs is 0.7% and for isoflurane 1.4%
[35]. As our intension was to simulate clinical
conditions during free flap surgery we chose to use a
combination of volatile anaesthetics with nitrous
oxide [35] and an opioid, which is a more common
practice than using volatile agents alone.
During normovolaemic conditions, there was no
significant difference between the two anaesthetic
groups in any of the central haemodynamic variables
(table 1, and figs 1 and 2). This may appear to
contrast with other studies which indicated that
halothane depresses myocardial contractility and CO
more than isoflurane [35—38]. However, as pointed
out above, relatively low doses of the volatile
anaesthetics (0.70 MAC) were used in our study.
Merin, Verdouw and de Jong have shown that when
halothane was given in a low concentration (0.65
MAC) in 60 % nitrous oxide, CO decreased by only
10% compared with awake controls, while a high
concentration (1.5 MAC) decreased CO by 32%
[34]. In the present study, haemorrhagic hypo-
volaemia produced a lower MAP and CO in group H
than in group I (figs 1, 2) perhaps because of less
pronounced effects of isoflurane on myocardial
contractility and coronary blood flow in pigs com-
pared with halothane [22, 23, 34, 35, 37, 39]. These
results are also in agreement with those of Seyde and
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Longnecker for hypovolaemic rats [17], but in
contrast with those of Weiskopf and colleagues for
hypovolaemic dogs [40].
The cause of the marked difference in effects of the
two volatile agents on blood flow in the skin of a
denervated flap during hypovolaemia may not appear
obvious. Severe blood loss may cause up to 10-fold
increase in noradrenaline and up to 50-fold increase
in adrenaline concentrations in circulating blood
[41], and both catecholamines are potent vaso-
constrictors in skin [42, 43]. Although the flaps were
denervated, circulating catecholamines could still
have reached the flap and caused vasoconstriction
[44, 45]. Bond and colleagues studied the effects of
hypovolaemia on blood flow (EMF) in denervated
skin in dogs [43, 46]. They found that increased
cutaneous vascular resistance in haemorrhage was
caused by elevated plasma catecholamines and was
unaffected by sympathetic nerves or circulating
angiotensin [43]. Thus it is possible that high
concentrations of circulating catecholamines con-
tributed to the decrease in blood flow in flap skin.
However, this does not explain the difference
between the two groups.
Most general anaesthetics depress the cardio-
vascular response to stress caused by blood loss or
surgical stimuli [17,40], but the literature on the
effects of halothane and isoflurane on plasma
catecholamines during anaesthesia and surgery is
conflicting. During oral surgery in children,
halothane—nitrous oxide caused significantly higher
plasma concentrations of catecholamines than
isoflurane-nitrous oxide anaesthesia [47] and during
hypotensive anaesthesia, lower catecholamine con-
centrations were found in patients given isoflurane
than in patients given halothane and sodium nitro-
prusside [48]. Others have not found any difference
in plasma concentrations of catecholamines between
the two volatile agents, either during undisturbed
anaesthesia or during surgery [49,50]. Several
mechanisms by which anaesthetics can influence
circulating concentrations of catecholamines have
been studied. First, they can influence noradrenaline
release (spillover rate) from nerve endings and the
clearance rate from the circulation. In high doses
(1.0—2.0 MAC) both anaesthetics decrease nor-
adrenaline spillover rate and clearance in dogs
[44,45]. The effects of lower doses of volatile
anaesthetics combined with nitrous oxide are, how-
ever, not known. Secondly, volatile anaesthetics can
influence stimulus-secretion coupling in the adrenal
medulla. Both halothane and isoflurane inhibit
carbachol-induced secretion of adrenaline and nor-
adrenaline in bovine chromaffin cells [51].
During normovolaemia, systemic blood flow (CO)
and pressure (MAP), and skin flow were comparable
in the two groups, while during hypovolaemia all
decreased significantly more in group H than in the
group I. Thus it may not be reasonable to assume
that reduced systemic flow and pressure resulted in
decreased blood flow and perfusion pressure in flap
skin. Additionally, systemic hypotension may have
resulted in more pronounced systemic catecholamine
release in group H than in group I [41, 48], causing
cutaneous vasoconstriction and further reduction in
MBF [43] in group H. While this may explain the
difference in MBF between the two groups, it does
not clarify why MBF decreased more in denervated
flap skin than in intact control skin in group H. One
explanation might be that the 90 min of flap
ischaemia with subsequent reperfusion and later
hypotension caused some microcirculatory dysfunc-
tion (e.g. endothelial injury), which was not de-
tectable with the LDF technique as long as systemic
flow and pressure remained normal. However, when
systemic pressure decreased the perfusion pressure
of the flap may have decreased below a critical level,
resulting in a further decrease in flap skin MBF.
Whether halothane and isoflurane have any specific
effects on endothelial cells or on the compliance
(flexibility) of erythrocytes and leucocytes during
ischaemic and reperfusion injury in skin is not
known.
After restoring circulating blood volume by re-
infusion of shed blood, CO and MAP returned to
baseline levels in both groups (figs 1 and 2). In
addition, flap muscle blood flow in both groups and
flap skin blood flow in group I increased to levels
even slightly higher than baseline (figs 4 and 5). In
group H, however, flap skin flow remained below
baseline levels, even after restoration of blood
volume, indicating that some, not immediately
reversible, microcirculatory disturbance had
occurred.
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